NEW YORK (360Dx) – Medical Research Organization NAMSA said this week it has launched its in vitro diagnostic development business to aid manufacturers expedite commercialization of its products. Based in Ohio, NAMSA offers its Uniquely IVD regulatory, quality, and clinical research services. Among the services the company provides are guidance on 510(k) submissions and CE marking, as well as clinical research, biostatistics, and data management, according to its website.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.